Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Testosterone, Desire, and Erection

Why T drives libido and nocturnal erections more than visually-stimulated rigidity

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Testosterone approved for hypogonadism; not approved to treat ED in eugonadal men

Reference only. Not medical advice.

What can go wrong

Testosterone replacement is appropriate only for men with biochemically confirmed hypogonadism (low morning testosterone on repeat testing plus symptoms), not as a generic libido or erection booster. Inappropriate TRT can suppress spermatogenesis and fertility, cause erythrocytosis, and is unnecessary in men with normal levels. Marketing that frames testosterone as a fix for erectile rigidity in eugonadal men is not supported by the physiology and may delay appropriate ED workup.

This is something to take to a clinician. The Atlas can tell you what is known about testosterone, desire, and erection in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Testosterone's role in male sexual function is specific and often misunderstood: it is a strong driver of sexual desire (libido) and of spontaneous/nocturnal erections, but a comparatively weak determinant of visually- or psychogenically-stimulated erectile rigidity in men whose levels are not low. Classic work by Bancroft, and the controlled studies of Carani and others, showed that androgen withdrawal blunts libido and nocturnal penile tumescence while sparing erections to erotic visual stimuli, and that a threshold rather than a linear dose-response governs the effect, above roughly the low-normal range, more testosterone does not mean more sexual function. This is why TRT reliably helps libido in genuinely hypogonadal men but is not a treatment for ED in men with normal testosterone.

Testosterone fuels wanting and night-time erections more than it rescues a failing one.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Restoring libido in confirmed hypogonadism
  • Distinguishing desire problems from vascular ED
  • Setting realistic expectations for TRT and sexual function

How it works

Androgens act on androgen receptors (and via aromatization to estradiol) in hypothalamic and limbic circuits, the MPOA, amygdala, and related regions, to maintain sexual motivation, and they support the neural and nitric-oxide machinery underlying spontaneous and sleep-related erections. Erections evoked by external erotic stimulation appear to recruit pathways less dependent on circulating testosterone, which is why such erections can persist despite low androgen levels. The threshold phenomenon means restoring testosterone from deficient to low-normal captures most of the sexual benefit.

The dissociation the marketing flattens

Direct-to-consumer TRT marketing tends to promise that testosterone fixes erections. The controlled physiology says otherwise: Carani and colleagues showed that hypogonadal men retain erections to erotic films while losing nocturnal erections and libido, and that replacement restores the androgen-dependent components selectively. Bancroft framed testosterone as the fuel for desire and the central, automatic erectile system rather than the on-demand, visually-cued one. Hence a eugonadal man with vascular ED needs a PDE5 inhibitor, not testosterone, and the TESTIM/TRT-for-ED narrative is frequently oversold.

Safety in detail

Testosterone therapy requires confirmed hypogonadism and physician monitoring (hematocrit, PSA, symptoms). It is not an evidence-based treatment for ED in men with normal testosterone.

Replacement is not the same as a cycle

Physiological replacement to the low-normal range captures essentially all of testosterone's sexual benefit (threshold effect). Supraphysiological dosing does not produce proportionally greater libido or erections and adds risks, erythrocytosis, fertility suppression, cardiovascular and mood effects, without sexual-function justification.

What it does to fertility

Exogenous testosterone suppresses the HPG axis and spermatogenesis, frequently impairing fertility; this is a key reason TRT is inappropriate as a casual libido enhancer in men wishing to conceive.

What people get wrong

  • Often saidHigher testosterone means stronger erections

    ActuallyAbove the low-normal threshold, more testosterone does not improve erectile rigidity. T drives desire and nocturnal erections; vascular erections depend on blood flow and nitric oxide, addressed by PDE5 inhibitors.

  • Often saidTRT is a treatment for erectile dysfunction

    ActuallyOnly when ED is caused by genuine hypogonadism. In men with normal testosterone, TRT is not an evidence-based ED therapy.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

How we got here

The androgen-dependence of male sexual behavior was established across decades of castration/replacement studies in animals and men. John Bancroft synthesized the human endocrinology from the 1980s; Cesare Carani's controlled studies in the early 1990s produced the influential dissociation between visually-stimulated and nocturnal erections. The threshold model emerged from replacement studies showing diminishing returns above low-normal testosterone.

At a glance

Strongly androgen-dependent
Libido; nocturnal/spontaneous erections
Relatively androgen-independent
Erections to erotic visual stimulation (in non-hypogonadal men)
Dose-response
Threshold, not linear, above low-normal, more T adds little
TRT for ED
Helps in true hypogonadism; not a treatment in eugonadal men

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Testosterone, Desire, and Erection. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Carani et al., androgens and erectile response to visual vs nocturnal stimuli1990-1995

    Showed androgen deprivation reduces libido and nocturnal erections while sparing erections to visual erotic stimulation; replacement selectively restores androgen-dependent components

  • Bancroft, the endocrinology of sexual arousal2005

    Synthesized testosterone's role as the driver of desire and central erectile mechanisms, distinct from peripheral/psychogenic arousal

  • Gray et al. / threshold studies of T and sexual function2005 onward

    Supported a threshold model in which sexual benefits of testosterone plateau above the low-normal range